Infection of both SARS-CoV-2 and a surrogate lenti-Spike were blocked by imatinib (Figs. 1a, 2b), a widely used inhibitor of the non-receptor Abl1 and Abl2 tyrosine kinases. Here, ABL1 is linked to infection.